Officially inaugurated by H.E Dr. Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and License Sector, UAE Ministry of Health

New regional HQ for world's 10th largest pharmaceutical company covers 70markets including Turkey, the Middle East Countries , Africa , Russia and the CIS

Dubai, UAE, 12 June2013:His Excellency Dr. Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and License Sector at the UAE Ministry of Health, recentlyofficially inaugurated Eli Lilly and Company's new regional headquarters for Turkey, Middle East, Africa, Russia and the CIS (TMEA-CIS) in Dubai Healthcare City, UAE.

Lilly, the world's tenth largest pharmaceutical company will manage its operations across more than 70 markets from its new base in Dubai. Lilly business areas cover Diabetes, Oncology, Bio -medicines and Animal Health. The new TMEA-CIS headquarters employ 75 persons.

In 1923 Lilly was the first company to commercially introduce insulin for the management of diabetes, andtoday the company continues to invest and innovate in the fields of diabetes research, education and management.

Speaking at the opening, HE Dr AlAmiri said: "The United Arab Emirates hosts 90% of the regional offices of the global pharmaceutical companies. We are very happy with Lilly's decision and initiative to establish a regional office in Dubai that covers several countries, beyond the Middle East Region".

He added: "The Ministry of Health is committed to encourage innovation and to bring the latest innovative and Generic products to the patients in the UAE".

Nabil Daoud, Vice President and Area Director, TMEA - CIS, Eli Lilly, said: "We chose the UAE as the base for our new regional headquarters because this country and its leadership have made a clear and coordinated commitment to quality healthcare and to create an environment that encourages and supports innovation in medical care and treatment.In addition, Its stability and geographic location, being close to a large number of emerging markets made it the country of choice for a Lilly regional hub".

"We arehonouredand privileged to have the support and presence of His Excellency Dr. Amin Hussain Al Amiriat our official office inauguration.  We look forward to contribute to the healthcare sector development in the UAE and the region by making available our innovative products to patients and helping them achieve longer and healthier lives."

Lilly currently has the richest mid-to-late stage pipeline in its history, representing a variety of therapeutic areas including cancer, diabetes , neuroscience and autoimmunity. It has been consistently ranked as one of the best companies in the world to work for.

-Ends-

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available atwww.lilly.com.

For more than 90 years, Lilly has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy - practical tools, education, and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journeys of each person living with or treating diabetes inspire ours.

For media information and interviews please contact:
Chloe Martinez at ASDA'A Burson-Marsteller, Dubai
Tel:       +971 4 4507 600
Email:   chloe.martinez@bm.com

© Press Release 2013